Key Takeaways
- Scale expansion delivered, CrudeChem ahead of plan: Consolidated income, EBITDA and PAT all grew sharply YoY, with the CrudeChem acquisition already doubling its business to a $100 mn annualized run-rate and reaching double-digit EBITDA margin a year early.
- Textile is no longer the story: The legacy textile business has fallen from 90% of revenue in 2022 to ~25%, not because it shrank but because oil & gas and hygiene/cleaning are scaling far faster.
- Water treatment is the next platform bet: A dedicated U.S. subsidiary has been formed, Fortune 10 NDAs are signed, and management now expects initial orders by Q4 FY27, pulled forward from FY28.
- Quarterly noise obscures the trend: CrudeChem revenue appeared flat QoQ, but management insists this is normal lumpiness in oilfield services and urges an annual view; COGS also saw temporary inventory destocking effects.
- What to watch next quarter: Whether the pulled-forward Q4 FY27 water treatment orders actually materialize, any disclosure on CrudeChem standalone numbers, and how the company funds its next acquisition without uncomfortable debt or dilution.
The CrudeChem Transformation
- Business doubled in under a year: The acquired U.S. oilfield chemicals platform has gone from a ~$50 mn pre-acquisition run-rate to $100 mn annualized, achieved in roughly 6–9 months of operations since closing in January.
- Margin turnaround delivered early: The 2-year target to bring CrudeChem from single-digit to double-digit EBITDA margin was achieved by Q4 of the acquisition year itself, and Q1/Q2 FY27 performance is faring as well or better than anticipated.
- Quarterly volatility is structural, not a warning: Revenue appeared flattish or slightly down QoQ from Q1 to Q2 FY27, but management attributes this to normal oilfield order lumpiness driven by well customization, weather, and customer delivery schedules, and advises viewing the business annually.
- $200 mn target by CY2028: Management has a plan in place and believes the trajectory is on track; if the business doubled in 6–9 months, the next doubling should happen in 6–7 quarters.
- Technology transfer is derisking supply chains: Product lines and technology were moved to CrudeChem’s U.S. facility to serve local demand and avoid high freight rates and Middle East port closures that made shipping from India unreliable.
- Stake increase is contracted: SPAs require CrudeChem founders to sell an additional 25% to Fineotex in January 2028, taking ownership to 79–80%.
Sanjay Tibrewala: “It's like a — how do I say, IPL match, you cannot watch every over and then translate that in 20 overs how much will be the run rate. So there will be certain power overs, which comes and does the job. So similarly, there are certain quarters which does the job of 2, 3 quarters.”
Water Treatment: The Next Platform
- New U.S. subsidiary formed: Fineotex America Inc. has been established as a wholly owned platform to serve data centers, semiconductors and advanced industrial facilities in water and wastewater management, separate from CrudeChem.
- Vision goes beyond chemicals: Management intends to build an integrated solutions platform spanning specialty water treatment chemistry, engineering, equipment, operational support and service partners across the water life cycle.
- Orders pulled forward: Initial water treatment orders were previously expected in Q1 FY28, but management now believes Q4 FY27 will have orders in hand due to completed approval processes.
- Fortune 10 NDAs signed: Top-tier companies have signed non-disclosure agreements with Fineotex for water treatment, though names remain confidential.
- Asset-light capex model: Management expects an asset turnover ratio of at least 5x to 6x on water treatment investments, with substantial cash on books and internal accruals available; open to debt or equity if needed.
- U.S. service culture is the pricing lever: Management notes that U.S. industrial customers are willing to pay for service and solutions, unlike the price-sensitive Indian market where buyers prefer cheaper products and self-manage.
Sanjay Tibrewala: “This is something which the world has never seen before.”
Oil & Gas: Tailwinds and Geography
- Middle East shifting sourcing to India: Middle East companies increasingly want to buy from India rather than China or the U.S. due to proximity and digestible freight rates; Fineotex is already supplying Aramco and other large customers from its Indian export operations.
- U.S. industrial investment is a direct tailwind: An expected $1.5 trillion of investment in U.S. semiconductors and data centers over the next 2 years, concentrated in Texas/Midland near CrudeChem’s plant, will drive significant water treatment and recycling demand.
- Canada entry underway: The company has started supplying to large service operators in Canada, and Guyana/Suriname are picking up as new oil-producing regions.
- Short-term contracts protect pricing: Oil and gas contracts run 1–2 months maximum; even Aramco has moved to spot purchases and war surcharges, allowing Fineotex to pass through raw material price changes within a couple of months.
- COGS spike was a timing issue, not competitive pressure: COGS rose 6% QoQ because chemicals ordered earlier arrived later due to longer Asia-to-U.S. transit times and geopolitical freight disruptions, landing when prices had already corrected, creating a temporary inventory destocking effect that should normalize.
Sanjay Tibrewala: “Most of the Middle East companies, they want to buy more products from India. They don't want to buy from China, U.S. and other ones because it's more closer to them, the freight rates are still digestible compared to the other areas.”
Margins and Financials
- Blended margin recovery expected: Management expects consolidated PAT margins to move closer to historical levels (FY24 peak ~21%, FY26 ~16%) over the coming couple of years, driven by sustainable, higher-margin products being developed for oil and gas customers.
- Other expenses normalizing: Other expenses dropped ~6% QoQ as elevated Q1 spending on technical hires, consultants and new CrudeChem product lines settled; operational efficiencies and new machines are delivering cost savings, and this lower run-rate is expected to continue.
- Other income declined: Reduced treasury investments, dividend incomes and foreign exchange effects drove a considerable drop in other income in Q2 FY27.
- Tax rate structurally lower: The blended tax rate is falling as the new Indian plant under FSPL Specialties is taxed at 15% under Section 115BAB, and the U.S. tax rate is lower; management expects 17–20% going forward, with 20% as a reasonable estimate.
- Credit rating upgraded: ICRA upgraded the long-term rating to ICRA AA- stable and reaffirmed the ICRA A1+ short-term rating.
Sanjay Tibrewala: “So when you look at the blended margins in the coming couple of years or wherever we are, you will see that we are closer to what you are looking at.”
Capital Allocation and M&A
- Any acquisition will be EBITDA-accretive: Management stated this as a firm condition for future deals.
- Debt aversion with a caveat: Management is not comfortable adding too much debt, but if debt is needed initially for an acquisition, it can be bridged later with an equity fundraise; the stance on equity dilution is neither a firm no nor a firm yes, depending on the opportunity.
- New investments go through new subsidiaries: Any new opportunities outside CrudeChem, including water treatment and potential Middle East JVs, will be routed through the newly incorporated, 100%-owned Fineotex Holdings Inc. and Fineotex America Inc., not through CrudeChem.
- Promoter warrants exercised: Promoter Sanjay Tibrewala subscribed to and exercised warrants in his individual capacity; proceeds are in the company’s books and being deployed for growth.
- M&A pipeline active: Management is seeing many opportunities from chemical companies for mergers, acquisitions and inorganic joint ventures, including an exciting prospect in Ras Al Khaimah and others in the U.S.
Sanjay Tibrewala: “We are not too comfortable on adding too much of a debt. Now having said that, in case we need some debt in the initial times and then we can bridge it up with other equity fund raise or wherever it is, we can always consider that.”
Segment Mix and Legacy Business
- Textile is now ~25% of revenue: Down from 90% in 2022, not because textile declined in absolute terms but because oil & gas and hygiene/cleaning verticals have scaled far faster; textile is now described as an “auto-run business” requiring minimal management focus.
- Textile recovery underway: The textile business, previously subdued by U.S. market dependence, chemical price spikes and geopolitical tariffs, is improving as India-UK and India-EU zero-tax arrangements take effect and U.S. tariffs return to original or lower levels; top bedsheet customers are showing better results.
- AquaStrike Premium progressing: The plant has been audited by CIB with registration certification received around September; Haffkine’s approval certification for product performance has been uploaded; the product should shape up within this financial year.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| CrudeChem revenue target | $200 mn revenue | Calendar year 2028 |
| CrudeChem stake increase | Additional 25% acquired from founders, taking ownership to 79–80% | January 2028 |
| Water treatment initial orders | Orders in hand expected | Q4 FY27 (pulled forward from Q1 FY28) |
| Blended tax rate | 17–20% going forward | Ongoing |
| Top-line growth (2030 view) | At least 3x to 4x from current levels | By ~2030 (6–7 years), assuming normal geopolitics and other factors |
| Other expenses run-rate | Remain in line with Q2 FY27 levels | Going forward |
| Acquisitions | Any deal will be EBITDA-accretive | Condition for all future M&A |
Key Metrics
| Metric | Q2 FY27 |
|---|---|
| Consolidated total income | ₹391 cr, +169% YoY |
| Operating EBITDA | ₹60 cr, +92% YoY |
| Profit after tax | ₹45 cr, +71% YoY |
| H1 FY27 consolidated total income | ₹778.13 cr, +166.8% YoY |
| H1 FY27 operating EBITDA | ₹118.74 cr, +111.2% YoY |
| H1 FY27 profit after tax | ₹92.75 cr, +81.5% YoY |
| H1 FY27 business volumes growth | +132.3% YoY |
| H1 FY27 consolidated ROIC | 36.12% |
| Effective tax rate | 21%, down from 25% in Q1 FY27 |
| Revenue split: oil and gas | ~65% of total revenue |
| Revenue split: textile specialties | ~25% of total revenue, down from 90% in FY22 but grown in absolute terms |
| Revenue split: cleaning and hygiene | ~7–8% of total revenue |
| CrudeChem annualized revenue run rate | $100 million, doubled from ~$50 million in the last year |
| CrudeChem sustainable product share | 44% of CrudeChem products |
| U.S. manufacturing stated annual capacity | 148,000 metric tons |
| CrudeChem controlling stake | ~54%, increasing to 79–80% by January 2028 |